Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-16

FDA Approved: LEVETIRACETAM — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved Somerset Therapeutics, LLC's original abbreviated new drug application for levetiracetam in sodium chloride, a generic formulation of levetiracetam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam in Sodium Chloride (LEVETIRACETAM IN SODIUM CHLORIDE)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM IN SODIUM CHLORIDE)